MannKind Corp. (MNKD)
5.91
+0.13
(+2.25%)
USD |
NASDAQ |
Feb 09, 16:00
5.925
+0.02
(+0.25%)
After-Hours: 20:00
MannKind Profit Margin (Quarterly) : 9.72% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 10.24% |
| Keros Therapeutics, Inc. | -51.04% |
| BioMarin Pharmaceutical, Inc. | -3.91% |
| Ionis Pharmaceuticals, Inc. | -82.06% |
| Vertex Pharmaceuticals, Inc. | 34.76% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | 6.72% |
| Return on Invested Capital | 24.74% |
| Gross Profit Margin (Quarterly) | 75.40% |
| Operating Margin (Quarterly) | 22.86% |
| Return on Net Operating Assets | 19.22% |